Literature DB >> 23280835

Mouse models of frontotemporal dementia.

Erik D Roberson1.   

Abstract

The pace of discovery in frontotemporal dementia (FTD) has accelerated dramatically with the discovery of new genetic causes and pathological substrates of the disease. MAPT/tau, GRN/progranulin, and C9ORF72 have emerged as common FTD genes, and TARDBP/TDP-43, VCP, FUS, and CHMP2B have been identified as less common genetic causes. TDP-43 and FUS have joined tau as common neuropathological substrates of the disease. Mouse models provide an important tool for understanding the role of these molecules in FTD pathogenesis. Here, we review recent progress with mouse models based on tau, TDP-43, progranulin, VCP, and CHMP2B. We also consider future prospects for FTD models, including developing new models to address unanswered questions. There are also opportunities for capitalizing on conservation of the salience network, which is selectively vulnerable in FTD, and the availability of FTD-related behavioral paradigms to analyze mouse models of the disease.
Copyright © 2012 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23280835      PMCID: PMC3539234          DOI: 10.1002/ana.23722

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  131 in total

1.  Core features of frontotemporal dementia recapitulated in progranulin knockout mice.

Authors:  N Ghoshal; J T Dearborn; D F Wozniak; N J Cairns
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

2.  Frontotemporal dementia progresses to death faster than Alzheimer disease.

Authors:  E D Roberson; J H Hesse; K D Rose; H Slama; J K Johnson; K Yaffe; M S Forman; C A Miller; J Q Trojanowski; J H Kramer; B L Miller
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

3.  Social modulation of pain as evidence for empathy in mice.

Authors:  Dale J Langford; Sara E Crager; Zarrar Shehzad; Shad B Smith; Susana G Sotocinal; Jeremy S Levenstadt; Mona Lisa Chanda; Daniel J Levitin; Jeffrey S Mogil
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

4.  Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.

Authors:  M J Kovach; B Waggoner; S M Leal; D Gelber; R Khardori; M A Levenstien; C A Shanks; G Gregg; M T Al-Lozi; T Miller; W Rakowicz; G Lopate; J Florence; G Glosser; Z Simmons; J C Morris; M P Whyte; A Pestronk; V E Kimonis
Journal:  Mol Genet Metab       Date:  2001-12       Impact factor: 4.797

5.  Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.

Authors:  Sara K Custer; Manuela Neumann; Hongbo Lu; Alexander C Wright; J Paul Taylor
Journal:  Hum Mol Genet       Date:  2010-02-10       Impact factor: 6.150

6.  Rat brains also have a default mode network.

Authors:  Hanbing Lu; Qihong Zou; Hong Gu; Marcus E Raichle; Elliot A Stein; Yihong Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

7.  Two systems of resting state connectivity between the insula and cingulate cortex.

Authors:  Keri S Taylor; David A Seminowicz; Karen D Davis
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

8.  TDP-43 is a developmentally regulated protein essential for early embryonic development.

Authors:  Chantelle F Sephton; Shannon K Good; Stan Atkin; Colleen M Dewey; Paul Mayer; Joachim Herz; Gang Yu
Journal:  J Biol Chem       Date:  2009-12-29       Impact factor: 5.157

9.  Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.

Authors:  Bradley F Boeve; Kevin B Boylan; Neill R Graff-Radford; Mariely DeJesus-Hernandez; David S Knopman; Otto Pedraza; Prashanthi Vemuri; David Jones; Val Lowe; Melissa E Murray; Dennis W Dickson; Keith A Josephs; Beth K Rush; Mary M Machulda; Julie A Fields; Tanis J Ferman; Matthew Baker; Nicola J Rutherford; Jennifer Adamson; Zbigniew K Wszolek; Anahita Adeli; Rodolfo Savica; Brendon Boot; Karen M Kuntz; Ralitza Gavrilova; Andrew Reeves; Jennifer Whitwell; Kejal Kantarci; Clifford R Jack; Joseph E Parisi; John A Lucas; Ronald C Petersen; Rosa Rademakers
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

10.  Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice.

Authors:  Sergey V Shmelkov; Adília Hormigo; Deqiang Jing; Catia C Proenca; Kevin G Bath; Till Milde; Evgeny Shmelkov; Jared S Kushner; Muhamed Baljevic; Iva Dincheva; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; George D Yancopoulos; Ipe Ninan; Francis S Lee; Shahin Rafii
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

View more
  36 in total

1.  Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies.

Authors:  Julio A Alfieri; Natalia S Pino; Lionel M Igaz
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Regulation of cathepsin D activity by the FTLD protein progranulin.

Authors:  Xiaolai Zhou; Daniel H Paushter; Tuancheng Feng; Cara M Pardon; Christina S Mendoza; Fenghua Hu
Journal:  Acta Neuropathol       Date:  2017-05-10       Impact factor: 17.088

3.  Alzheimer's disease-causing proline substitutions lead to presenilin 1 aggregation and malfunction.

Authors:  Tziona Ben-Gedalya; Lorna Moll; Michal Bejerano-Sagie; Samuel Frere; Wayne A Cabral; Dinorah Friedmann-Morvinski; Inna Slutsky; Tal Burstyn-Cohen; Joan C Marini; Ehud Cohen
Journal:  EMBO J       Date:  2015-10-05       Impact factor: 11.598

4.  Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.

Authors:  Kevin H Strang; Cara L Croft; Zachary A Sorrentino; Paramita Chakrabarty; Todd E Golde; Benoit I Giasson
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

Review 5.  TDP-43 in the spectrum of MND-FTLD pathologies.

Authors:  Lanier Heyburn; Charbel E-H Moussa
Journal:  Mol Cell Neurosci       Date:  2017-07-04       Impact factor: 4.314

Review 6.  Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.

Authors:  Huntington Potter; Antoneta Granic; Julbert Caneus
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 7.  The role of CHMP2BIntron5 in autophagy and frontotemporal dementia.

Authors:  Christopher S Krasniak; S Tariq Ahmad
Journal:  Brain Res       Date:  2016-03-10       Impact factor: 3.252

8.  C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD.

Authors:  Jacqueline G O'Rourke; Laurent Bogdanik; A K M G Muhammad; Tania F Gendron; Kevin J Kim; Andrew Austin; Janet Cady; Elaine Y Liu; Jonah Zarrow; Sharday Grant; Ritchie Ho; Shaughn Bell; Sharon Carmona; Megan Simpkinson; Deepti Lall; Kathryn Wu; Lillian Daughrity; Dennis W Dickson; Matthew B Harms; Leonard Petrucelli; Edward B Lee; Cathleen M Lutz; Robert H Baloh
Journal:  Neuron       Date:  2015-12-02       Impact factor: 17.173

9.  Wild-type bone marrow transplant partially reverses neuroinflammation in progranulin-deficient mice.

Authors:  Yue Yang; Macarena S Aloi; Eiron Cudaback; Samuel R Josephsen; Samantha J Rice; Nikolas L Jorstad; C Dirk Keene; Thomas J Montine
Journal:  Lab Invest       Date:  2014-09-08       Impact factor: 5.662

Review 10.  Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.

Authors:  Cutler T Lewandowski; Juan Maldonado Weng; Mary Jo LaDu
Journal:  Neurobiol Dis       Date:  2020-02-20       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.